When 35.7% More Matters: General Electric Company Introduces Invenia ABUS

Published: Dec 02, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHICAGO--(BUSINESS WIRE)--GE Healthcare, a unit of General Electric Company (NYSE:GE), introduced today the new Invenia Automated Breast Ultrasound System (ABUS) at the 2013 Radiological Society of North America (#RSNA13) annual meeting. ABUS is used to answer the need of detecting additional cancer in women where mammography alone may be insufficient due to their greater breast density. Featuring new automated compression tools for enhanced workflow and ergonomics†, the automated breast ultrasound system provides physicians a new way to look at dense breast tissue that can allow them to improve breast cancer detection by up to 35.7 percent over mammography alone.

Help employers find you! Check out all the jobs and post your resume.

Back to news